VaST’s technology is solidly in the sweet spot of speed and accuracy, accurate enough to be a surrogate for the hardware from an analysis point of view, and fast enough to be a surrogate for the ...
Prior software revenue growth view was 6%-13%. Drug discovery revenue is now expected to range from $20 million to $30 million. Software gross margin is expected to ...